Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
TScan Therapeutics, Inc. Income Statement Banner

TScan Therapeutics, Inc. Income Statement

TCRX Stock Analysis

Page title

Section title

Breakdown
2019
2020
2021
2022
2023
Total Revenue
0.0001.085M10.141M13.535M21.049M
Cost of Revenue
519.000K20.577M3.328M5.137M5.361M
Gross Profit
-519.000k-19.492m6.813M8.398M15.688M
Operating Expense
14.210M27.318M58.782M80.171M109.146M
Operating Income
-14.210m-26.233m-48.641m-66.636m-93.458m
Other Income Expense
0.0000.00016.000K1.591M0.000
Total Other Income Expense
552.000K106.000K16.000K415.000K4.240M
Pretax Income
-13.658m-26.127m-48.625m-66.221m-89.218m
Tax Provision
-552.000k-106.000k3.091M-415.000k5.193M
Net Income
-13.106m-26.021m-48.625m-65.806m-89.218m
Basic EPS
-0.530-1.040-2.030-2.740-1.360
Diluted EPS
-0.530-1.040-2.030-2.740-1.360
Basic Average Shares
24.938M24.938M23.908M24.048M65.600M
Diluted Average Shares
24.938M24.938M23.908M24.048M65.600M
Total Expenses
14.210M27.318M58.782M80.171M114.507M
Interest Income
552.000K106.000K16.000K1.591M7.999M
Interest Expense
0.0000.0000.0001.176M3.759M
EBITDA
-13.691m-25.003m-45.313m-65.045m-88.097m
Depreciation & Amortization
519.000K1.230M3.328M5.137M5.361M